Compound Detail

CHEMBL114325

AMIGLUMIDE

🧪 Phase II

Enter ChEMBL ID:

Free Research Context This compound will appear in recent viewed items on the research home for this browser.

🧪 Phase II

CCCCCN(CCCCC)C(=O)[C@@H](CCC(=O)O)NC(=O)c1ccc2ccccc2c1

ChEMBL ↗ Properties Compare Identifier

Basic Information

ChEMBL ID	CHEMBL114325
Name	AMIGLUMIDE
Phase	Phase II
Structure Type	MOL
InChI Key	LFMMKOQRKPJBIG-HSZRJFAPSA-N

Amiglumida Amiglumide CR-1795 CR1795

Targets

Activities

Assay Types

PK Parameters

Publications

Known Names

440.6

MW (Da)

5.01

ALogP

HBA

HBD

86.7

PSA (Å²)

0.40

QED

Ro5 Violations

Rot. Bonds

Molecule Type	Small molecule
Chirality	Single Enantiomer

USAN Stem

-glumide

IC50 5 meas. best 7.92

Target	Type	Best pChEMBL	Mean pChEMBL	Best (nM)	# Data
Cholecystokinin receptor type A CHEMBL3501	IC50	7.92	7.0733	12.0	3
Cavia porcellus CHEMBL369	IC50	7.44	7.44	36.0	2

Top measurements by pChEMBL value

Target	Type	Rel.	Value	Units	pChEMBL	Assay	PubMed
Cholecystokinin receptor type A	IC50	=	12.0	nM	7.92	Compound was evaluated for the binding affinity against Cholecystokinin type A r...	2704023
Cholecystokinin receptor type A	IC50	=	12.0	nM	7.92	Inhibition of [125I]Bolton-Hunter CCK-8 binding to cholecystokinin type A recept...	1766000
Cavia porcellus	IC50	=	36.0	nM	7.44	Compound was evaluated for the ability to inhibit CCK-stimulated amylase release...	2704023
Cavia porcellus	IC50	=	36.0	nM	7.44	Inhibition of CCK-8-stimulated amylase release	1766000
Cholecystokinin receptor type A	IC50	=	4200.0	nM	5.38	Compound was evaluated for the binding affinity against Cholecystokinin type A r...	2704023

PubMed	DOI	Target Context	# Activities
2704023	10.1021/jm00124a003	Cholecystokinin receptor type A	2
2704023	10.1021/jm00124a003	Cavia porcellus	1
1766000	10.1021/jm00116a002	Cholecystokinin receptor type A	1
1766000	10.1021/jm00116a002	Cavia porcellus	1

Data from ChEMBL 36 via Core Engine